Targeting EFHD2 Inhibits Interferon-gamma Signaling and Ameliorates Non-Alcoholic Steatohepatitis. Fu JT, Liu J, Wu WB, Chen YT, et al. J Hepatol 2024 Apr 24:S0168-8278(24)00277-0. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Fu JT, Liu J, Wu WB, Chen YT, et al. Targeting EFHD2 Inhibits Interferon-gamma Signaling and Ameliorates Non-Alcoholic Steatohepatitis. J Hepatol 2024 Apr 24:S0168-8278(24)00277-0. doi: 10.1016/j.jhep.2024.
PMID: 38670321